Gupta, Preeti <br/><br/>
Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Oct 2019 
 - 109245 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2019.109245  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>A549 Cells<br/>Antineoplastic Agents--pharmacology<br/>Cell Death--drug effects<br/>Cell Proliferation--drug effects<br/>Ellagic Acid--chemistry<br/>HEK293 Cells<br/>Humans<br/>Molecular Docking Simulation<br/>Molecular Targeted Therapy<br/>Phosphotransferases (Alcohol Group Acceptor)--antagonists & inhibitors<br/>Principal Component Analysis<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Structure, Secondary<br/>Recombinant Proteins--isolation & purification<br/>Spectrometry, Fluorescence<br/>Thermodynamics